| The receptor tyrosine kinase Axl in cancer: biological functions and therapeutic implications JD Paccez, M Vogelsang, MI Parker, LF Zerbini International journal of cancer 134 (5), 1024-1033, 2014 | 169 | 2014 |
| The versatility of the fungal cytochrome P450 monooxygenase system is instrumental in xenobiotic detoxification L Lah, B Podobnik, M Novak, B Korošec, S Berne, M Vogelsang, ... Molecular microbiology 81 (5), 1374-1389, 2011 | 96 | 2011 |
| The cumulative effects of polymorphisms in the DNA mismatch repair genes and tobacco smoking in oesophageal cancer risk M Vogelsang, Y Wang, N Veber, LM Mwapagha, MI Parker PloS one 7 (5), e36962, 2012 | 58 | 2012 |
| MicroRNA polymorphisms and environmental smoke exposure as risk factors for oesophageal squamous cell carcinoma Y Wang, M Vogelsang, G Schaefer, M Matejcic, MI Parker PloS one 8 (10), e78520, 2013 | 45 | 2013 |
| Genetic markers of pigmentation are novel risk loci for uveal melanoma R Ferguson, M Vogelsang, E Ucisik-Akkaya, K Rai, R Pilarski, ... Scientific reports 6 (1), 31191, 2016 | 40 | 2016 |
| Identification of a novel pathogenic germline KDR variant in melanoma IP Silva, A Salhi, KM Giles, M Vogelsang, SW Han, N Ismaili, KP Lui, ... Clinical Cancer Research 22 (10), 2377-2385, 2016 | 40 | 2016 |
| Wharton’s jelly-derived mesenchymal stromal cells and fibroblast-derived extracellular matrix synergistically activate apoptosis in a p21-dependent mechanism in WHCO1 and MDA … K Dzobo, M Vogelsang, NE Thomford, C Dandara, K Kallmeyer, ... Stem cells international 2016, 2016 | 34 | 2016 |
| Wnt/β-catenin and MEK-ERK signaling are required for fibroblast-derived extracellular matrix-mediated endoderm differentiation of embryonic stem cells K Dzobo, M Vogelsang, MI Parker Stem Cell Reviews and Reports 11, 761-773, 2015 | 34 | 2015 |
| Aberrant methylation of the MSH3 promoter and distal enhancer in esophageal cancer patients exposed to first-hand tobacco smoke M Vogelsang, JD Paccez, G Schäfer, K Dzobo, LF Zerbini, MI Parker Journal of cancer research and clinical oncology 140, 1825-1833, 2014 | 28 | 2014 |
| NAT1 and NAT2 genetic polymorphisms and environmental exposure as risk factors for oesophageal squamous cell carcinoma: a case-control study M Matejcic, M Vogelsang, Y Wang, IM Parker BMC cancer 15, 1-14, 2015 | 22 | 2015 |
| The expression quantitative trait loci in immune pathways and their effect on cutaneous melanoma prognosis M Vogelsang, CN Martinez, J Rendleman, A Bapodra, K Malecek, ... Clinical Cancer Research 22 (13), 3268-3280, 2016 | 21 | 2016 |
| Genetic associations of the interleukin locus at 1q32. 1 with clinical outcomes of cutaneous melanoma J Rendleman, M Vogelsang, A Bapodra, C Adaniel, I Silva, D Moogk, ... Journal of medical genetics 52 (4), 231-239, 2015 | 19 | 2015 |
| Assessing pathogenicity of MLH1 variants by co-expression of human MLH1 and PMS2genes in yeast M Vogelsang, A Comino, N Zupanec, P Hudler, R Komel BMC cancer 9, 1-9, 2009 | 18 | 2009 |
| Germline determinants of clinical outcome of cutaneous melanoma M Vogelsang, M Wilson, T Kirchhoff Pigment cell & melanoma research 29 (1), 15-26, 2016 | 16 | 2016 |
| Non-truncating hMLH1 variants identified in Slovenian gastric cancer patients are not associated with Lynch Syndrome: a functional analysis report M Vogelsang, R Komel Familial cancer 10, 255-263, 2011 | 6 | 2011 |
| Genetic instability in gastric cancer P Hudler, M Vogelsang, R Komel Gastric Carcinoma-Molecular Aspects and Current Advances, 2011 | 5 | 2011 |
| Germline determinants of immune related adverse events (irAEs) in melanoma immunotherapy response T Kirchhoff, R Ferguson, D Simpson, E Kazlow, C Martinez, M Vogelsang, ... Annals of Oncology 28, v407-v408, 2017 | 4 | 2017 |
| Novel germline risk loci in familial melanoma (FM). E Kazlow, R Ferguson, D Simpson, CN Martinez, M Vogelsang, U Moran, ... Journal of Clinical Oncology 35 (15_suppl), 1535-1535, 2017 | 1 | 2017 |
| Functional genomics to identify germline markers of melanoma immunotherapy efficacy and toxicity R Ferguson, D Simpson, C Martinez, M Vogelsang, E Kazlow, M Wilson, ... JOURNAL OF TRANSLATIONAL MEDICINE 16, 2018 | | 2018 |
| Immunotherapy Bridge 2017 and Melanoma Bridge 2017: meeting abstracts D Carbone, M Sharpnack, K He, LH Butterfield, AMM Eggermont, ... Journal of Translational Medicine 16, 1-15, 2018 | | 2018 |
Ankush SharmaAstrazenecaVerified email at astrazeneca.com
Ankush SharmaAstrazenecaVerified email at astrazeneca.com